VA official warns of device malware; Three firms to locate facilities in Penang;

> At a congressional hearing last week, Roger Baker, assistant secretary for information and technology at the Department of Veterans Affairs, said during the past 14 months more than 122 medical devices have been compromised by malware. Story

> Three medical device multi-national corporations (MNCs) are planning to set up manufacturing facilities in Penang, lending further credibility to the state's growth as a medical device hub. News

> Fears are growing for jobs at a medical devices company in the midlands. Management is due to brief workers at the Covidien plant this afternoon. According to reports, the company may be seeking as many as 100-200 redundancies. Report

> Stryker and Acuitec inked a strategic marketing plan for their perioperative management software. Article

> Boston Scientific, the Natick medical device maker, announced the start of a clinical trial to evaluate the performance of its PROMUS Element Everolimus-Eluting Coronary Stent System. Story

> Johnson & Johnson's Cordis unit said Tuesday that patient-outcome trends in a key study for its "Nevo" medicated heart stents continued to favor the devices after a year. Item

> Cardiovascular Systems has completed patient enrollment in its COMPLIANCE 360° clinical trial, part of the company's 360° Clinical Series. Release

And Finally... A scientist at the University of Reading has become the first human to be infected with a computer virus as part of research into the potential risks associated with electronic devices implanted into humans. Report

Suggested Articles

The ADDF announced its second round of research awards, with a total of $6 million in new funding for diagnostic tests.

Takeda teamed up with Enzyre to develop an at-home diagnostic device that will help people with hemophilia determine their own coagulation status.

Foundation Medicine received a diagnostic approval from the FDA for selecting HR+/HER2- breast cancer patients for treatment with Novartis' Piqray.